Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.96
+0.01000.13%
Post-market: 7.960.00000.00%19:13 EDT
Volume:22.27K
Turnover:177.76K
Market Cap:54.09M
PE:-0.70
High:8.15
Open:7.94
Low:7.80
Close:7.95
Loading ...

Atara Biotherapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
12 Jun

Atara Biotherapeutics Files Initial Beneficial Ownership Statement for Director Nachiappan Subramanian

Reuters
·
24 May

Atara Biotherapeutics Inc. Files Initial Beneficial Ownership Statement; Redmile Group's Jeremy Green Listed as Director

Reuters
·
24 May

Atara Biotherapeutics Inc. Files Initial Statement of Beneficial Ownership Naming Panacea Innovation Ltd as Owner

Reuters
·
22 May

Top Executives at Atara Biotherapeutics Make Significant Stock Sales!

TIPRANKS
·
21 May

Atara Biotherapeutics' Chief Accounting Officer Yanina Grant-Huerta Reports Disposal of Common Shares

Reuters
·
21 May

Atara Biotherapeutics CEO AnhCo Nguyen Reports Disposal of Common Shares

Reuters
·
21 May

Atara Biotherapeutics Reports Strong Q1 2025 Results

TIPRANKS
·
17 May

Atara Biotherapeutics Inc. Appoints James Huang and Nachi Subramanian to Board of Directors Following Successful $16 Million Offering

Reuters
·
17 May

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors

THOMSON REUTERS
·
17 May

Atara Biotherapeutics Announces $16M Stock Offering

TIPRANKS
·
17 May

Buy Rating for Atara Biotherapeutics: Strategic Focus and Financial Positioning Ahead of Key FDA Meeting

TIPRANKS
·
16 May

BUZZ-U.S. STOCKS ON THE MOVE-Xponential Fitness, Phillips 66, Amazon.com

Reuters
·
16 May

BUZZ-Atara Biotherapeutics rises after direct stock offering, business update

Reuters
·
15 May

Atara Biotherapeutics Q1 EPS $3.50 Beats $(1.98) Estimate, Sales $98.15M Beat $5.67M Estimate

Benzinga
·
15 May

Atara Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Atara Biotherapeutics Reports Q1 2025 Net Income of $38M with EPS of $3.53, Reversing Previous Year's Loss

Reuters
·
15 May

BRIEF-Atara Biotherapeutics Q1 EPS USD 3.5

Reuters
·
15 May

Atara Biotherapeutics Inc. Announces $16 Million Share Offering to Fund Biologics License Application Activities

Reuters
·
15 May

Atara Biotherapeutics Announces First Quarter Financial Results and Operational Progress

THOMSON REUTERS
·
15 May